Atherosclerosis progression was more than twice as common in younger people with systemic lupus erythematosus (SLE) than in ...

A-319 is under clinical development by ITabMed and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase I drugs for Systemic Lupus Erythematosus have a 73% phase ...

Scientists at the Oklahoma Medical Research Foundation are one step closer to determining the genetic trigger for lupus in ...

A new study explored the potential of IncRNA CASC2 and miR-155 levels as non-invasive diagnostic biomarkers for systemic lupus erythematosus (SLE) and lupus nephritis (LN). Previous studies have found ...

Cori Broadus shares her journey through a recent stroke and recovery, revealing the dangers of stopping medication cold turkey.

Legendary R&B singer Eddie Levert is mourning the loss of his daughter, Ryan Levert. The O’Jays singer’s grandchildren, ...

Felzartamab is under clinical development by Biogen and currently in Phase I for Lupus Nephritis. According to GlobalData, Phase I drugs for Lupus Nephritis have an 84% phase transition success rate ...

An analysis of 2024 Google search data revealed the top health questions asked by Americans. A registered nurse provides ...

EMBL scientists uncover potential use of an FDA-approved over-the-counter cough syrup ingredient to treat fibrotic lung ...

Now, scientists at Stanford University have found that a faulty genetic molecule could be responsible for the immune system misidentifying healthy tissue as a threat. The breakthrough study, published ...

If reading about these atrocities churns your stomach, reflect on what is going on before our eyes these very days ...

In a new study published in Lupus Science & Medicine, researchers explored the efficacy of using a combination of belimumab and standard immunotherapy compared to standard immunotherapy alone in ...